Features and Outcomes of 899 Patients With Drug-Induced Liver Injury: The DILIN Prospective Study

2015/03/06 by Naga Chalasani, Herbert L. Bonkovsky, Robert Fontana +97 · 29 citations
Pharmacology, Toxicology and Pharmaceutics · Medicine · #Drug-Induced Hepatotoxicity and Protection #Poisoning and overdose treatments #Hepatitis C virus research

paper · pdf · doi:10.1053/j.gastro.2015.03.006

Citations

• Drug-Induced Liver Injury: An Analysis of 461 Incidences Submitted to the Spanish Registry Over a 10-Year Period
• Causes, Clinical Features, and Outcomes From a Prospective Study of Drug-Induced Liver Injury in the United States

Cited by

• Beyond Hy's Law: Importance of Markedly Elevated Aminotransferases without Hyperbilirubinemia
• Diagnosis and Management of Autoimmune Hepatitis in Adults and Children: 2019 Practice Guidance and Guidelines From the American Association for the Study of Liver Diseases
• Clinical and Genetic Associations in Cephalosporin‐Induced Liver Injury: Insights From the Drug‐Induced Liver Injury Network
• N-acetyltransferase (NAT) 1 and NAT2 enzyme activities drive interindividual variability in sulfamethoxazole N-acetylation
• Mechanisms of adaptation and progression in idiosyncratic drug induced liver injury, clinical implications. [europepmc]
• RUCAM in Drug and Herb Induced Liver Injury: The Update. [europepmc]
• Hepatotoxicity by Drugs: The Most Common Implicated Agents. [europepmc]
• Clinical Features and Outcomes of Complementary and Alternative Medicine Induced Acute Liver Failure and Injury. [europepmc]
• Definition and risk factors for chronicity following acute idiosyncratic drug-induced liver injury. [europepmc]
• Features of Autoimmune Hepatitis in Patients With Drug-induced Liver Injury. [europepmc]
• Drug-induced liver injury. [europepmc]
• Clinical presentations and outcomes of bile duct loss caused by drugs and herbal and dietary supplements. [europepmc]
• Drug-induced liver injury: recent advances in diagnosis and risk assessment. [europepmc]
• Drug-Induced Liver Injury: Cascade of Events Leading to Cell Death, Apoptosis or Necrosis. [europepmc]
• Death and liver transplantation within 2 years of onset of drug-induced liver injury. [europepmc]
• Role of nonalcoholic fatty liver disease as risk factor for drug-induced hepatotoxicity. [europepmc]
• Drug-induced cholestasis. [europepmc]
• The British Society of Gastroenterology/UK-PBC primary biliary cholangitis treatment and management guidelines. [europepmc]
• Pancreatitis in Children. [europepmc]
• Mitochondrial dysfunction as a mechanism of drug-induced hepatotoxicity: current understanding and future perspectives. [europepmc]
• Acute-on-chronic liver failure: consensus recommendations of the Asian Pacific association for the study of the liver (APASL): an update. [europepmc]
• Acute liver failure. [europepmc]
• Molecular Biomarkers in Drug-Induced Liver Injury: Challenges and Future Perspectives. [europepmc]
• Knowledge Mapping of Drug-Induced Liver Injury: A Scientometric Investigation (2010-2019). [europepmc]
• Incidence, risk factors, and prognosis of abnormal liver biochemical tests in COVID-19 patients: a systematic review and meta-analysis. [europepmc]
• Recent updates on the management of autoimmune hepatitis. [europepmc]
• Oxidative Stress in Drug-Induced Liver Injury (DILI): From Mechanisms to Biomarkers for Use in Clinical Practice. [europepmc]
• Management of Acute Liver Failure: Update 2022. [europepmc]
• Liver diseases: epidemiology, causes, trends and predictions. [europepmc]